Spectrum of flurodeoxyglucose positron emission tomography/computerized tomography findings in tumors and tumor-like conditions of the musculoskeletal system

Bone and soft-tissue tumors display a wide range of metabolic activity on flurodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT) imaging due to their varying histopathological features. Several benign tumors show high FDG uptake similar to that seen in malignant lesions...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of nuclear medicine 2021-07, Vol.36 (3), p.327-339
Main Authors: Purandare, Nilendu, Shah, Sneha, Agrawal, Archi, Puranik, Ameya, Rangarajan, Venkatesh
Format: Article
Language:English
Subjects:
Cancer
Computed tomography
Diagnosis
Imaging techniques
Lesions
Medical imaging
Metabolism
Musculoskeletal system
Osteochondroma
PET imaging
Pictorial
Positron emission
Prognosis
Tomography
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3
cites cdi_FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3
container_end_page 339
container_issue 3
container_start_page 327
container_title Indian journal of nuclear medicine
container_volume 36
creator Purandare, Nilendu
Shah, Sneha
Agrawal, Archi
Puranik, Ameya
Rangarajan, Venkatesh
description Bone and soft-tissue tumors display a wide range of metabolic activity on flurodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT) imaging due to their varying histopathological features. Several benign tumors show high FDG uptake similar to that seen in malignant lesions and their metabolic characteristics can overlap. Certain benign tumors can potentially undergo malignant transformation and FDG PET/CT can play an important role in detecting malignant change. The intensity of metabolic activity on FDG PET/CT correlates with histological grade of malignant tumors and also acts as a valuable prognostic factor. FDG PET/CT plays an important role in the staging work up of bone and soft-tissue malignancies. It has been found to be superior to conventional imaging techniques primarily for detecting distant metastatic disease. Because of its ability to detect metabolic changes, FDG PET/CT is a very useful in assessing response to treatment. Metabolic response seen on FDG PET is a powerful surrogate marker of histopathological response to chemotherapy. The purpose of this article is to study the variable patterns of FDG uptake in tumors of the musculoskeletal system, describe the clinical utility of FDG PET/CT in predicting malignant change in benign tumors and discuss its role in staging, response assessment, and prognostication of malignant lesions.
doi_str_mv 10.4103/ijnm.ijnm_242_20
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8481850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A676883530</galeid><sourcerecordid>A676883530</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3</originalsourceid><addsrcrecordid>eNp1kk-P0zAQxSMEYpeFO8dISIhLuo6dOMkFaVnxT1qJA3C2HHvSurUzwY4p5bvwXXHbBboIFCkZTX7vjTx-Wfa0JIuqJOzSrEe32L8Eraig5F52TrqmKgitqvuHmhasK7uz7FEIa0J41XD-MDtjFa_bmtPz7MfHCdTso8txyAcbPWrAb7uljQoD5BMGM3scc3AmBJOKGR0uvZxWu0uFboozePMd9Ek_H8yozbgMuUl4dOhDLkd9LAtrNpArTMSc7MJ-7LyC3MWgosWwAQuztHnYhRnc4-zBIG2AJ7ffi-zzm9efrt8VNx_evr--uilUXbeukIx1fSu1llrWDa-YViBb6Ie-oT1nnJWqoQNra92onpe81lRKSprUgK7pFLvIXh59p9g7SOpx9tKKyRsn_U6gNOLun9GsxBK_irZqy7YmyeDFrYHHLxHCLNK-FFgrR8AYBK1bxiglFUvos7_QNUY_puMlquEtaZLnH2opLQgzDpjmqr2puOKJalnN9mMX_6DSo9N9pSXDYFL_juD5iWAF0s6rgDYe7uIuSI6g8hiCh-H3Mkoi9tkTh9idZC9JXh0lW7QpFWFj4xa8SFvbjLj9r04w2ohfKWQ_ATA96qY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576807481</pqid></control><display><type>article</type><title>Spectrum of flurodeoxyglucose positron emission tomography/computerized tomography findings in tumors and tumor-like conditions of the musculoskeletal system</title><source>Publicly Available Content Database</source><source>Medknow Open Access Medical Journals</source><source>PubMed Central</source><creator>Purandare, Nilendu ; Shah, Sneha ; Agrawal, Archi ; Puranik, Ameya ; Rangarajan, Venkatesh</creator><creatorcontrib>Purandare, Nilendu ; Shah, Sneha ; Agrawal, Archi ; Puranik, Ameya ; Rangarajan, Venkatesh</creatorcontrib><description>Bone and soft-tissue tumors display a wide range of metabolic activity on flurodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT) imaging due to their varying histopathological features. Several benign tumors show high FDG uptake similar to that seen in malignant lesions and their metabolic characteristics can overlap. Certain benign tumors can potentially undergo malignant transformation and FDG PET/CT can play an important role in detecting malignant change. The intensity of metabolic activity on FDG PET/CT correlates with histological grade of malignant tumors and also acts as a valuable prognostic factor. FDG PET/CT plays an important role in the staging work up of bone and soft-tissue malignancies. It has been found to be superior to conventional imaging techniques primarily for detecting distant metastatic disease. Because of its ability to detect metabolic changes, FDG PET/CT is a very useful in assessing response to treatment. Metabolic response seen on FDG PET is a powerful surrogate marker of histopathological response to chemotherapy. The purpose of this article is to study the variable patterns of FDG uptake in tumors of the musculoskeletal system, describe the clinical utility of FDG PET/CT in predicting malignant change in benign tumors and discuss its role in staging, response assessment, and prognostication of malignant lesions.</description><identifier>ISSN: 0972-3919</identifier><identifier>EISSN: 0974-0244</identifier><identifier>DOI: 10.4103/ijnm.ijnm_242_20</identifier><identifier>PMID: 34658562</identifier><language>eng</language><publisher>Mumbai: Wolters Kluwer India Pvt. Ltd</publisher><subject>Cancer ; Computed tomography ; Diagnosis ; Imaging techniques ; Lesions ; Medical imaging ; Metabolism ; Musculoskeletal system ; Osteochondroma ; PET imaging ; Pictorial ; Positron emission ; Prognosis ; Tomography ; Tumors</subject><ispartof>Indian journal of nuclear medicine, 2021-07, Vol.36 (3), p.327-339</ispartof><rights>COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.</rights><rights>2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2021 Indian Journal of Nuclear Medicine 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3</citedby><cites>FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481850/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2576807481?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27458,27924,27925,37012,37013,44590,53791,53793</link.rule.ids></links><search><creatorcontrib>Purandare, Nilendu</creatorcontrib><creatorcontrib>Shah, Sneha</creatorcontrib><creatorcontrib>Agrawal, Archi</creatorcontrib><creatorcontrib>Puranik, Ameya</creatorcontrib><creatorcontrib>Rangarajan, Venkatesh</creatorcontrib><title>Spectrum of flurodeoxyglucose positron emission tomography/computerized tomography findings in tumors and tumor-like conditions of the musculoskeletal system</title><title>Indian journal of nuclear medicine</title><description>Bone and soft-tissue tumors display a wide range of metabolic activity on flurodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT) imaging due to their varying histopathological features. Several benign tumors show high FDG uptake similar to that seen in malignant lesions and their metabolic characteristics can overlap. Certain benign tumors can potentially undergo malignant transformation and FDG PET/CT can play an important role in detecting malignant change. The intensity of metabolic activity on FDG PET/CT correlates with histological grade of malignant tumors and also acts as a valuable prognostic factor. FDG PET/CT plays an important role in the staging work up of bone and soft-tissue malignancies. It has been found to be superior to conventional imaging techniques primarily for detecting distant metastatic disease. Because of its ability to detect metabolic changes, FDG PET/CT is a very useful in assessing response to treatment. Metabolic response seen on FDG PET is a powerful surrogate marker of histopathological response to chemotherapy. The purpose of this article is to study the variable patterns of FDG uptake in tumors of the musculoskeletal system, describe the clinical utility of FDG PET/CT in predicting malignant change in benign tumors and discuss its role in staging, response assessment, and prognostication of malignant lesions.</description><subject>Cancer</subject><subject>Computed tomography</subject><subject>Diagnosis</subject><subject>Imaging techniques</subject><subject>Lesions</subject><subject>Medical imaging</subject><subject>Metabolism</subject><subject>Musculoskeletal system</subject><subject>Osteochondroma</subject><subject>PET imaging</subject><subject>Pictorial</subject><subject>Positron emission</subject><subject>Prognosis</subject><subject>Tomography</subject><subject>Tumors</subject><issn>0972-3919</issn><issn>0974-0244</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kk-P0zAQxSMEYpeFO8dISIhLuo6dOMkFaVnxT1qJA3C2HHvSurUzwY4p5bvwXXHbBboIFCkZTX7vjTx-Wfa0JIuqJOzSrEe32L8Eraig5F52TrqmKgitqvuHmhasK7uz7FEIa0J41XD-MDtjFa_bmtPz7MfHCdTso8txyAcbPWrAb7uljQoD5BMGM3scc3AmBJOKGR0uvZxWu0uFboozePMd9Ek_H8yozbgMuUl4dOhDLkd9LAtrNpArTMSc7MJ-7LyC3MWgosWwAQuztHnYhRnc4-zBIG2AJ7ffi-zzm9efrt8VNx_evr--uilUXbeukIx1fSu1llrWDa-YViBb6Ie-oT1nnJWqoQNra92onpe81lRKSprUgK7pFLvIXh59p9g7SOpx9tKKyRsn_U6gNOLun9GsxBK_irZqy7YmyeDFrYHHLxHCLNK-FFgrR8AYBK1bxiglFUvos7_QNUY_puMlquEtaZLnH2opLQgzDpjmqr2puOKJalnN9mMX_6DSo9N9pSXDYFL_juD5iWAF0s6rgDYe7uIuSI6g8hiCh-H3Mkoi9tkTh9idZC9JXh0lW7QpFWFj4xa8SFvbjLj9r04w2ohfKWQ_ATA96qY</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Purandare, Nilendu</creator><creator>Shah, Sneha</creator><creator>Agrawal, Archi</creator><creator>Puranik, Ameya</creator><creator>Rangarajan, Venkatesh</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P5Z</scope><scope>P62</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210701</creationdate><title>Spectrum of flurodeoxyglucose positron emission tomography/computerized tomography findings in tumors and tumor-like conditions of the musculoskeletal system</title><author>Purandare, Nilendu ; Shah, Sneha ; Agrawal, Archi ; Puranik, Ameya ; Rangarajan, Venkatesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer</topic><topic>Computed tomography</topic><topic>Diagnosis</topic><topic>Imaging techniques</topic><topic>Lesions</topic><topic>Medical imaging</topic><topic>Metabolism</topic><topic>Musculoskeletal system</topic><topic>Osteochondroma</topic><topic>PET imaging</topic><topic>Pictorial</topic><topic>Positron emission</topic><topic>Prognosis</topic><topic>Tomography</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Purandare, Nilendu</creatorcontrib><creatorcontrib>Shah, Sneha</creatorcontrib><creatorcontrib>Agrawal, Archi</creatorcontrib><creatorcontrib>Puranik, Ameya</creatorcontrib><creatorcontrib>Rangarajan, Venkatesh</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Purandare, Nilendu</au><au>Shah, Sneha</au><au>Agrawal, Archi</au><au>Puranik, Ameya</au><au>Rangarajan, Venkatesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spectrum of flurodeoxyglucose positron emission tomography/computerized tomography findings in tumors and tumor-like conditions of the musculoskeletal system</atitle><jtitle>Indian journal of nuclear medicine</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>36</volume><issue>3</issue><spage>327</spage><epage>339</epage><pages>327-339</pages><issn>0972-3919</issn><eissn>0974-0244</eissn><abstract>Bone and soft-tissue tumors display a wide range of metabolic activity on flurodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT) imaging due to their varying histopathological features. Several benign tumors show high FDG uptake similar to that seen in malignant lesions and their metabolic characteristics can overlap. Certain benign tumors can potentially undergo malignant transformation and FDG PET/CT can play an important role in detecting malignant change. The intensity of metabolic activity on FDG PET/CT correlates with histological grade of malignant tumors and also acts as a valuable prognostic factor. FDG PET/CT plays an important role in the staging work up of bone and soft-tissue malignancies. It has been found to be superior to conventional imaging techniques primarily for detecting distant metastatic disease. Because of its ability to detect metabolic changes, FDG PET/CT is a very useful in assessing response to treatment. Metabolic response seen on FDG PET is a powerful surrogate marker of histopathological response to chemotherapy. The purpose of this article is to study the variable patterns of FDG uptake in tumors of the musculoskeletal system, describe the clinical utility of FDG PET/CT in predicting malignant change in benign tumors and discuss its role in staging, response assessment, and prognostication of malignant lesions.</abstract><cop>Mumbai</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>34658562</pmid><doi>10.4103/ijnm.ijnm_242_20</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0972-3919
ispartof Indian journal of nuclear medicine, 2021-07, Vol.36 (3), p.327-339
issn 0972-3919
0974-0244
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8481850
source Publicly Available Content Database; Medknow Open Access Medical Journals; PubMed Central
subjects Cancer
Computed tomography
Diagnosis
Imaging techniques
Lesions
Medical imaging
Metabolism
Musculoskeletal system
Osteochondroma
PET imaging
Pictorial
Positron emission
Prognosis
Tomography
Tumors
title Spectrum of flurodeoxyglucose positron emission tomography/computerized tomography findings in tumors and tumor-like conditions of the musculoskeletal system
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A11%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spectrum%20of%20flurodeoxyglucose%20positron%20emission%20tomography/computerized%20tomography%20findings%20in%20tumors%20and%20tumor-like%20conditions%20of%20the%20musculoskeletal%20system&rft.jtitle=Indian%20journal%20of%20nuclear%20medicine&rft.au=Purandare,%20Nilendu&rft.date=2021-07-01&rft.volume=36&rft.issue=3&rft.spage=327&rft.epage=339&rft.pages=327-339&rft.issn=0972-3919&rft.eissn=0974-0244&rft_id=info:doi/10.4103/ijnm.ijnm_242_20&rft_dat=%3Cgale_pubme%3EA676883530%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c558m-a339b8addada57643dcea8ebfb72b63631c72f385d7cb6165d2aa20785de979c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2576807481&rft_id=info:pmid/34658562&rft_galeid=A676883530&rfr_iscdi=true